Georgios Gkizas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Georgios Gkizas has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Andreas G. Tzakos
Department of Chemistry, Section of Organic Chemistry and Biochemistry, University of Ioannina, 45110 Ioannina, Greece
1 shared publication - Athanassios P. Kyritsis
Neurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece
1 shared publication - Eftichia Tsoumeleka
Neurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece
1 shared publication - Evrysthenis Vartholomatos
Department of Clinical Radiology, University Hospital of Ioannina, University Campus, 45110 Ioannina, Greece
1 shared publication - Georgios A. Alexiou
Neurosurgical Institute, University of Ioannina, 45110 Ioannina, Greece
1 shared publication - Georgios Bozios
Department of Radiation Oncology, University of Ioannina, 451 10 Ioannina, Greece
1 shared publication
Latest Publications
- Open Access
- 28 October 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (11) , 1562
Curcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro
Curcumin, a bioactive polyphenol, is known to have anticancer properties. In this study, the effectiveness of curcumin pretreatment as a strategy for radio-sensitizing glioblastoma cell lines was explored. For this, U87 and T98 cells were treated with curcumin, exposed to 2 Gy or 4 Gy of irradiation, and the combined effect was compared to the antiproliferative effect of each agent when given individually. Cell viability and proliferation were evaluated with the trypan blue exclusion assay and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The synergistic effects of the combination treatment were analyzed with CompuSyn software. To examine how the co-treatment affected different phases of cell-cycle progression, a cell-cycle analysis via flow cytometry was performed. Treatment with curcumin and radiation significantly reduced cell viability in both U87 and T98 cell lines. The combination treatment arrested both cell lines at the G2/M phase to a higher extent than radiation or curcumin treatment alone. The synergistic effect of curcumin when combined with temozolomide resulted in increased tumor cell death. Our results demonstrate for the first time that low doses of curcumin and irradiation exhibit a strong synergistic anti-proliferative effect on glioblastoma cells in vitro. Therefore, this combination may represent an innovative and promising strategy for the treatment of glioblastoma, and further studies are needed to fully understand the molecular mechanism underlying this effect.
- 28 October 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (11) , 1562
Open AccessCurcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro
Curcumin, a bioactive polyphenol, is known to have anticancer properties. In this study, the effectiveness of curcumin pretreatment as a strategy for radio-sensitizing glioblastoma cell lines was explored. For this, U87 and T98 cells were treated with curcumin, exposed to 2 Gy or 4 Gy of irradiation, and the combined effect was compared to the antiproliferative effect of each agent when given individually. Cell viability and proliferation were evaluated with the trypan blue exclusion assay and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The synergistic effects of the combination treatment were analyzed with CompuSyn software. To examine how the co-treatment affected different phases of cell-cycle progression, a cell-cycle analysis via flow cytometry was performed. Treatment with curcumin and radiation significantly reduced cell viability in both U87 and T98 cell lines. The combination treatment arrested both cell lines at the G2/M phase to a higher extent than radiation or curcumin treatment alone. The synergistic effect of curcumin when combined with temozolomide resulted in increased tumor cell death. Our results demonstrate for the first time that low doses of curcumin and irradiation exhibit a strong synergistic anti-proliferative effect on glioblastoma cells in vitro. Therefore, this combination may represent an innovative and promising strategy for the treatment of glioblastoma, and further studies are needed to fully understand the molecular mechanism underlying this effect.